TMDX

TransMedics Group, Inc.

TMDX · CIK 1756262 · Annual (10-K) · Last 7 years

Financial Trends

Revenue$605M
20192025
Net Income$190M
20192025
Operating CF$193M
20192025
Free Cash Flow$134M
20192025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Revenue$0.6B$0.4B$0.2B$0.1B$0.0B$0.0B$0.0B
Cost of Revenue$0.2B$0.2B$0.1B$0.0B$0.0B$0.0B$0.0B
Gross Profit$0.4B$0.3B$0.2B$0.1B$0.0B$0.0B$0.0B
R&D Expense$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense$0.2B$0.2B$0.1B$0.1B$0.0B$0.0B$0.0B
Operating Income$0.1B$0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$0.2B$0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$5.60$1.07$-0.77$-1.23$-1.60——
EPS (Diluted)$4.87$1.01$-0.77$-1.23$-1.60——

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Total Assets$1.1B$0.8B$0.7B$0.3B$0.1B$0.2B$0.1B
Current Assets$0.6B$0.5B$0.5B$0.3B$0.1B$0.1B$0.1B
Cash & Equivalents$0.5B$0.3B$0.4B$0.2B$0.0B$0.0B$0.0B
Total Liabilities$0.6B$0.6B$0.6B$0.1B$0.1B$0.0B$0.1B
Current Liabilities$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.5B$0.2B$0.1B$0.2B$0.1B$0.1B$0.1B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Operating Cash Flow$0.2B$0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$-0.1B$-0.1B$-0.2B$0.1B$0.0B$-0.0B$-0.1B
Capital Expenditures$0.1B$0.1B$0.2B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$0.4B$0.2B$0.0B$0.1B$0.1B
← Companies